BAILII [Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback]

United Kingdom Statutory Instruments


You are here: BAILII >> Databases >> United Kingdom Statutory Instruments >> The Medicines for Human Use (Prescribing by EEA Practitioners) (Amendment) Regulations 2010 No. 1673
URL: http://www.bailii.org/uk/legis/num_reg/2010/uksi_20101673_en_1.html

[New search] [Help]


 

The Medicines for Human Use (Prescribing by EEA Practitioners) (Amendment) Regulations 2010

Made

23rd June 2010

Laid before Parliament

28th June 2010

Coming into force

26th July 2010

The Secretary of State makes the following Regulations in the exercise of the powers conferred by section 2(2) of the European Communities Act 1972(1). He has been designated for the purpose of section 2(2) of the European Communities Act 1972(2) in relation to medicinal products.

Citation, commencement and interpretation

1.–(1) These Regulations may be cited as the Medicines for Human Use (Prescribing by EEA Practitioners) (Amendment) Regulations 2010 and shall come into force on 26th July 2010.

(2) In these Regulations "the principal Regulations" means the Medicines for Human Use (Prescribing by EEA Practitioners) Regulations 2008(3).

Amendment of regulation 3 of the principal Regulations

2. In regulation 3 of the principal Regulations (prescriptions given by EEA health professionals), in paragraph (2)(c)(iv) omit ", address and the age, if under 12,".

Signed by the authority of the Secretary of State for Health.

Earl Howe

Parliamentary Under-Secretary of State,

Department of Health

23rd June 2010

EXPLANATORY NOTE

(This note is not part of the Regulations)

These Regulations amend regulation 3 of the Medicines for Human Use (Prescribing by EEA Practitioners) Regulations 2008 relating to prescriptions provided by doctors and dentists in an EEA State other than the UK or in Switzerland to ensure that there is no longer a requirement for such prescriptions to contain details of the address and the age, if under 12, of the person for whose treatment the prescription is given.

An impact assessment has not been prepared for this instrument as there is no significant impact on the private and voluntary sectors.

(1)

1972 c.68; section 2(2) was amended by section 27(1)(a) of the Legislative and Regulatory Reform Act 2006 (c.51) and by section 3(3) of and Part 1 of Schedule 1 to the European Union (Amendment) Act 2008 (c.7). Back [1]

(2)

S.I. 1972/1811. Back [2]

(3)

S.I. 2008/1692. Back [3]



BAILII: Copyright Policy | Disclaimers | Privacy Policy | Feedback | Donate to BAILII
URL: http://www.bailii.org/uk/legis/num_reg/2010/uksi_20101673_en_1.html